Jeff Wrana

Researcher
  • Lunenfeld-Tanenbaum Research Institute
  • Sinai Health
  • University of Toronto
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Multiple Cancers

    Targeting the Hippo Signaling Network in Cancer

    In order to grow, cancers must overcome a series of mechanisms that control the normal functioning of our cells. One such mechanism is known as the “Hippo” pathway. “The main job of ...

    Read More
  • Completed
    Breast Cancer

    Characterization and treatment response of Hippo pathway regulated tumour microenvironments

    To grow, cancers overcome a series of biological mechanisms that control our normal cell functions. The “Hippo” pathway is one of these mechanisms. When it’s working correctly, it en...

    Read More
  • Completed
    Colorectal Cancer

    Targeting the hippo signaling network in cancer - 1

    In order for cancer to grow inside our bodies, it must overcome a series of control mechanisms that are important for tissue growth. One mechanism which is responsible for body organ size is aptly cal...

    Read More
  • Completed
    Brain Cancer

    Modeling and therapeutic targeting of the clinical and genetic diversity in glioblastoma multiforme

    Glioblastoma is a deadly brain cancer that currently has no cure, and has lagged behind major treatment advances other cancers have benefited from. But there’s hope: an Alberta-based, TFRI-funde...

    Read More
  • Completed
    All Cancers

    Genetic analysis of signaling pathways for vascular development and tumorigenesis

    Blocking blood vessel formation through anti-angiogenic therapy may kill cancerous tumours, but it can also cause potentially deadly side-effects for patients – a dilemma that Dr. Andras Nagy an...

    Read More

Related News & Events

  • Research Highlight|October 21, 2021

    Study identifies that all cancers can be classified into two groups based on presence of YAP protein: Q&A with Dr. Rod Bremner

    A group of researchers partly funded by the TFRI has found that all cancers can be classified into two distinct groups based on the presence of a prot...

  • Research Highlight|December 10, 2020

    Two New Frontiers Program Project Grant teams receive $10.9 million for research excellence, expansion to new key areas

    Two outstanding teams in Ontario will receive $10.9 million over the next six years to advance research into key areas of cancer development after bei...

  • Press Release|September 07, 2016

    TFRI ANNOUNCES 2016 FUNDING COMPETITION AWARD RECIPIENTS

    Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cance...

  • All News & Events